| # | Drug | Count |
|---|---|---|
| 0 | CYTARABINE | 5 |
| 1 | VENETOCLAX | 4 |
| 2 | AZACITIDINE | 2 |
| 3 | CARBOPLATIN | 2 |
| 4 | DOCETAXEL | 2 |
| 5 | DOCETAXEL ANHYDROUS | 2 |
| 6 | ELTROMBOPAG | 2 |
| 7 | ELTROMBOPAG OLAMINE | 2 |
| 8 | GRANULOCYTE COLONY STIMULATING FACTOR | 2 |
| 9 | ROSUVASTATIN | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GRANULOCYTE COLONY STIMULATING FACTOR | 2 | 0.0009 |
| 1 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 1 | 0.0004 |
| 2 | GEMTUZUMAB OZOGAMICIN | 1 | 0.0003 |
| 3 | GILTERITINIB | 1 | 0.0002 |
| 4 | RADIUM RA 223 DICHLORIDE | 1 | 0.0002 |
| 5 | TRETINOIN | 1 | 0.0001 |
| 6 | PITAVASTATIN CALCIUM | 1 | 0.0001 |
| 7 | ELTROMBOPAG OLAMINE | 2 | 0.0001 |
| 8 | PEGFILGRASTIM | 1 | 0.0001 |
| 9 | CYTARABINE | 5 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthracycline Topoisomerase Inhibitor [EPC] | 1 | 0.0004 |
| 1 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 2 | BCL-2 Inhibitor [EPC] | 4 | 0.0001 |
| 3 | Antimycobacterial [EPC] | 1 | 0.0000 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 7 | 0.0000 |
| 5 | Leukocyte Growth Factor [EPC] | 2 | 0.0000 |
| 6 | HER2/neu Receptor Antagonist [EPC] | 1 | 0.0000 |
| 7 | Microtubule Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Nucleoside Analog Antiviral [EPC] | 1 | 0.0000 |
| 9 | Nitrate Vasodilator [EPC] | 1 | 0.0000 |